Placebo to match LY3540378
J3E-MC-EZDB
Phase 2 small_molecule active
Quick answer
Placebo to match LY3540378 for Heart Failure with Preserved Ejection Fraction, Heart Failure is a Phase 2 program (small_molecule) at Eli Lilly Co. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Eli Lilly Co.
- Indication
- Heart Failure with Preserved Ejection Fraction, Heart Failure
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active